Similar Items: Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
- An anti-SARS-CoV-2 quantitative study to determine the effect of time on the antibody titre, post-vaccination
- New Variant of SARS-CoV-2 Dynamics with Imperfect Vaccine
- Characterising the magnitude and breadth of T cell responses to SARS-CoV-2 vaccination
- Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2–naïve individuals
- Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa
- Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection